| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Vassilis P Kontaxakis, Beata J Havaki-Kontaxaki, Nikolaos G Christodoulou, Konstantinos G Paplos, George N Christodoulo. Olanzapine-associated neuroleptic malignant syndrome: Is there an overlap with the serotonin syndrome? Annals of general hospital psychiatry. vol 2. issue 1. 2020-09-30. PMID:14613516. |
results: the serotonin syndrome clinical features most often reported in cases initially diagnosed as neuroleptic malignant syndrome are: fever (82%), mental status changes (82%) and diaphoresis (47%). |
2020-09-30 |
2023-08-12 |
Not clear |
| Vassilis P Kontaxakis, Beata J Havaki-Kontaxaki, Nikolaos G Christodoulou, Konstantinos G Paplos, George N Christodoulo. Olanzapine-associated neuroleptic malignant syndrome: Is there an overlap with the serotonin syndrome? Annals of general hospital psychiatry. vol 2. issue 1. 2020-09-30. PMID:14613516. |
conclusion: the results of this study show that the clinical symptoms of olanzapine-induced neuroleptic malignant syndrome and serotonin syndrome are overlapping suggesting similarities in underlying pathophysiological mechanisms. |
2020-09-30 |
2023-08-12 |
Not clear |
| Theeba Krishnamoorthy, John Knighton, Louis Merto. The role of electroencephalography in the diagnosis of serotonin syndrome. Journal of the Intensive Care Society. vol 17. issue 3. 2020-09-30. PMID:28979500. |
this case highlights the necessity of considering serotonin syndrome alongside other differential diagnoses: neuroleptic malignant syndrome, infectious cause, atypical seizures and delirium tremens, in the setting of altered mental state with abnormal neurology. |
2020-09-30 |
2023-08-13 |
Not clear |
| Marine Aussedat, Annie Lavoie, Jean-François Bussières, Niina Kleibe. Suspected Overlap Between Serotonin Syndrome and Neuroleptic Malignant Syndrome in a Child Treated With Metoclopramide? The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. vol 25. issue 6. 2020-09-28. PMID:32839660. |
suspected overlap between serotonin syndrome and neuroleptic malignant syndrome in a child treated with metoclopramide? |
2020-09-28 |
2023-08-13 |
Not clear |
| Marine Aussedat, Annie Lavoie, Jean-François Bussières, Niina Kleibe. Suspected Overlap Between Serotonin Syndrome and Neuroleptic Malignant Syndrome in a Child Treated With Metoclopramide? The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. vol 25. issue 6. 2020-09-28. PMID:32839660. |
the clinical course of the patient was suggestive of neuroleptic malignant syndrome (nms) and serotonin syndrome (ss), which can both be triggered by metoclopramide. |
2020-09-28 |
2023-08-13 |
Not clear |
| Michael Ott, Ursula Wernek. A Mixed Presentation of Serotonin Syndrome Versus Neuroleptic Malignant Syndrome in a 12-Year-Old Boy. Pediatric emergency care. vol 35. issue 5. 2020-01-07. PMID:30964850. |
a mixed presentation of serotonin syndrome versus neuroleptic malignant syndrome in a 12-year-old boy. |
2020-01-07 |
2023-08-13 |
Not clear |
| Haris Hakeem, Memoona Nasir, Muhammad Farhan Khan, Nabeel Muzaffar Syed, Haris Majid Rajput, Arsalan Ahmed, Muhammad Athar Javed, Danish Ejaz Bhatt. Recognizing Movement Disorder Emergencies - A Practical Review For Non-Neurologist. Journal of Ayub Medical College, Abbottabad : JAMC. vol 31. issue 3. 2019-12-17. PMID:31535526. |
movement disorder emergencies can be classified based on md phenomenology and we will provide a brief overview of dystonia including acute dystonic reaction, paid syndrome and dystonic storm; chorea, myoclonus including serotonin syndrome and startle disease; and rigidity including neuroleptic malignant syndrome and malignant hyperthermia. |
2019-12-17 |
2023-08-13 |
Not clear |
| Matthew I Hardman, Juraj Sprung, Toby N Weingarte. Acute phenibut withdrawal: A comprehensive literature review and illustrative case report. Bosnian journal of basic medical sciences. vol 19. issue 2. 2019-12-09. PMID:30501608. |
neurologic and autonomic signs and symptoms may mimic serotonin or neuroleptic malignant syndrome. |
2019-12-09 |
2023-08-13 |
Not clear |
| Mercedes Fernández, Laura Lago, M Gema Alonso, Ana Guede, Jose Luis Benavente, Jose M Olivare. Serotonin syndrome versus neuroleptic malignant syndrome: a case report. Actas espanolas de psiquiatria. vol 46. issue 2. 2019-06-03. PMID:29616715. |
serotonin syndrome versus neuroleptic malignant syndrome: a case report. |
2019-06-03 |
2023-08-13 |
Not clear |
| Suraj Rajan, Bonnie Kaas, Emile Moukheibe. Movement Disorders Emergencies. Seminars in neurology. vol 39. issue 1. 2019-04-15. PMID:30743298. |
here we review the clinical phenomenology, and diagnostic principles of neuroleptic malignant syndrome, malignant catatonia, serotonin syndrome, parkinsonism hyperpyrexia, acute parkinsonism, acute chorea-ballism, drug-induced dystonia, and status dystonicus. |
2019-04-15 |
2023-08-13 |
Not clear |
| Laura M Tormoehlen, Daniel E Rusynia. Neuroleptic malignant syndrome and serotonin syndrome. Handbook of clinical neurology. vol 157. 2019-03-04. PMID:30459031. |
neuroleptic malignant syndrome and serotonin syndrome. |
2019-03-04 |
2023-08-13 |
Not clear |
| Laura M Tormoehlen, Daniel E Rusynia. Neuroleptic malignant syndrome and serotonin syndrome. Handbook of clinical neurology. vol 157. 2019-03-04. PMID:30459031. |
the aim of this chapter is to review two of the most common drug-induced hyperthermic states, serotonin syndrome and neuroleptic malignant syndrome. |
2019-03-04 |
2023-08-13 |
Not clear |
| Kimberly Kwei, Steven Fruch. Acute Presentation of Nonmotor Symptoms in Parkinson's Disease. International review of neurobiology. vol 134. 2018-04-27. PMID:28805591. |
among these are neuroleptic malignant syndrome, serotonin syndrome, dopamine agonist withdrawal syndrome, and dystonic storm. |
2018-04-27 |
2023-08-13 |
Not clear |
| Ursula Werneke, Fariba Jamshidi, David M Taylor, Michael Ot. Conundrums in neurology: diagnosing serotonin syndrome - a meta-analysis of cases. BMC neurology. vol 16. 2017-01-02. PMID:27406219. |
here we test the validity of four assumptions that have become widely accepted: (1) the hunter classification performs clinically better than the sternbach and radomski criteria; (2) in contrast to neuroleptic malignant syndrome, the onset of serotonin syndrome is usually rapid; (3) hyperthermia is a hallmark of severe serotonin syndrome; and (4) serotonin syndrome can readily be distinguished from neuroleptic malignant syndrome on clinical grounds and on the basis of medication history. |
2017-01-02 |
2023-08-13 |
Not clear |
| Koichi Nisijim. Serotonin syndrome overlapping with neuroleptic malignant syndrome: A case report and approaches for differentially diagnosing the two syndromes. Asian journal of psychiatry. vol 18. 2016-09-26. PMID:26506919. |
serotonin syndrome overlapping with neuroleptic malignant syndrome: a case report and approaches for differentially diagnosing the two syndromes. |
2016-09-26 |
2023-08-13 |
Not clear |
| Koichi Nisijim. Serotonin syndrome overlapping with neuroleptic malignant syndrome: A case report and approaches for differentially diagnosing the two syndromes. Asian journal of psychiatry. vol 18. 2016-09-26. PMID:26506919. |
serotonin syndrome (ss) and neuroleptic malignant syndrome (nms) are life-threatening adverse reactions caused by serotonergic antidepressants and neuroleptics, respectively. |
2016-09-26 |
2023-08-13 |
Not clear |
| Elliot T Dawson, Sara E Hocke. Neurologic Complications of Commonly Used Drugs in the Hospital Setting. Current neurology and neuroscience reports. vol 16. issue 4. 2016-08-04. PMID:26905071. |
we include a practical approach to the diagnosis of serotonin syndrome and neuroleptic malignant syndrome. |
2016-08-04 |
2023-08-13 |
human |
| Linn E Katus, Steven J Fruch. Management of Serotonin Syndrome and Neuroleptic Malignant Syndrome. Current treatment options in neurology. vol 18. issue 9. 2016-07-29. PMID:27469512. |
management of serotonin syndrome and neuroleptic malignant syndrome. |
2016-07-29 |
2023-08-13 |
Not clear |
| Linn E Katus, Steven J Fruch. Management of Serotonin Syndrome and Neuroleptic Malignant Syndrome. Current treatment options in neurology. vol 18. issue 9. 2016-07-29. PMID:27469512. |
serotonin syndrome (ss) and neuroleptic malignant syndrome (nms) can present similarly and range in severity from mild to life-threatening. |
2016-07-29 |
2023-08-13 |
Not clear |
| Faizan Mazhar, Shahzad Akram, Nafis Haider, Rafeeque Ahme. Overlapping of Serotonin Syndrome with Neuroleptic Malignant Syndrome due to Linezolid-Fluoxetine and Olanzapine-Metoclopramide Interactions: A Case Report of Two Serious Adverse Drug Effects Caused by Medication Reconciliation Failure on Hospital Admission. Case reports in medicine. vol 2016. 2016-07-19. PMID:27433163. |
overlapping of serotonin syndrome with neuroleptic malignant syndrome due to linezolid-fluoxetine and olanzapine-metoclopramide interactions: a case report of two serious adverse drug effects caused by medication reconciliation failure on hospital admission. |
2016-07-19 |
2023-08-13 |
Not clear |